The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease
- 1 August 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (2) , 400-405
Abstract
We have analysed the quantitative expression of surface CD69 antigen on human mast cells (MC), from both normal and pathological bone marrow (BM) samples, using flow cytometry. Our major aim was to analyse whether CD69 is constitutively expressed by normal BMMC and to explore the possible differences between CD69 expression by BMMC from normal controls and patients suffering from different pathological conditions.The constitutive expression of surface CD69 was clearly demonstrated in BMMC; however, systemic mast cell disease (SMCD) patients showed significantly higher levels of surface CD69 expression than healthy controls (P < 0.001), chronic lymphocytic leukaemia (P = 0.001), monoclonal gammopathy of unknown significance (P < 0.001), multiple myeloma (P < 0.001) patients, and myelodysplastic syndromes (P = 0.002). Furthermore, almost no overlap between the levels of CD69 expression on BMMC was observed between SMCD cases and the remaining groups of individuals except for the paediatric mastocytosis group (P > 0.05). From the other groups of patients, monoclonal gammopathy of unknown significance (P = 0.04), myelodysplastic syndromes (P = 0.03) and paediatric mastocytosis (P = 0.003) cases showed a significantly higher expression of surface CD69 as compared to normal subjects.In summary, our findings show that the CD69 antigen is overexpressed in SMCD patients.Keywords
This publication has 27 references indexed in Scilit:
- CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activityLupus, 1997
- Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.Journal of Experimental Medicine, 1994
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994
- Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytesEuropean Journal of Immunology, 1993
- Regional sublocalization of the human CD69 gene to chromosome bands 12p12.3‐p13.2, the predicted region of the human natural killer cell gene complexEuropean Journal of Immunology, 1993
- Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigensEuropean Journal of Immunology, 1993
- CD69, An Early Activation Antigen on Lymphocytes, Is Constitutively Expressed by Human Epidermal Langerhans CellsJournal of Investigative Dermatology, 1992
- CD69 is expressed on platelets and mediates platelet activation and aggregation.Journal of Experimental Medicine, 1990
- Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.Journal of Experimental Medicine, 1988
- Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.Journal of Experimental Medicine, 1988